Literature DB >> 17264452

Intrathecal tetanus immunoglobulins in the management of tetanus.

M G Geeta1, P Krishnakumar, Lulu Mathews.   

Abstract

OBJECTIVE: To study the clinical profile, treatment and outcome of tetanus in children treated with intrathecal tetanus immunoglobulin. (TIG)
METHODS: Retrospective analysis of hospital records of tetaus cases admitted to the pediatric ICU during the five year period between 1999 to 2004 was done.
RESULTS: There were 66 cases of tetanus treated with intrathecal TIG. Children below 5 years formed 53% of cases and 47% were above 5 years. Totally unimmunized children constituted 82% of cases and 18% partially immunized children. The portal of entry was otogenic in 58% of cases and injury in30% of cases. The common complications observed included thrombophlebitis, aspiration pneumonia, laryngospasm and autonomic system involvement. There were no complications specific to intrathecal administration of TIG. The mortality due to tetanus was 9%. DISCUSSION: Mortality and morbidity due to tetanus was less in the present study compared to other centers where TIG is given intramuscularly.
CONCLUSION: Intrathecal TIG is effective in the treatment of mild and moderate tetanus. Randomized controlled clinical trials are needed to evaluate the efficacy of intrathecal TIG in the management of severe tetanus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264452     DOI: 10.1007/s12098-007-0025-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  8 in total

1.  Experience of pediatric tetanus cases from Mumbai.

Authors:  M S Tullu; C T Deshmukh; J R Kamat
Journal:  Indian Pediatr       Date:  2000-07       Impact factor: 1.411

2.  Intrathecal immunoglobulin in the treatment of tetanus.

Authors:  Janaki Menon; Lulu Mathews
Journal:  Indian Pediatr       Date:  2002-07       Impact factor: 1.411

3.  Grading of tetanus to evaluate prognosis.

Authors:  J C PATEL; G G JOAG
Journal:  Indian J Med Sci       Date:  1959-10

4.  A randomized double-blind sham-controlled study of intrathecal human anti-tetanus immunoglobulin in the management of tetanus.

Authors:  M Agarwal; K Thomas; J V Peter; L Jeyaseelan; A M Cherian
Journal:  Natl Med J India       Date:  1998 Sep-Oct       Impact factor: 0.537

5.  Tetanus: study of 8,697 cases.

Authors:  J C Patel; B C Mehta
Journal:  Indian J Med Sci       Date:  1999-09

6.  Upsurge in neonatal tetanus in Benin City, Nigeria.

Authors:  A I Omoigberale; P O Abiodun
Journal:  East Afr Med J       Date:  2005-02

7.  Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route.

Authors:  Demócrito de Barros Miranda-Filho; Ricardo Arraes de Alencar Ximenes; Antônio Alci Barone; Vicente Luiz Vaz; Aderbal Gomes Vieira; Valéria Maria Gonçalves Albuquerque
Journal:  BMJ       Date:  2004-03-05

8.  Intrathecal human tetanus immunoglobulin in early tetanus.

Authors:  P S Gupta; R Kapoor; S Goyal; V K Batra; B K Jain
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

  8 in total
  8 in total

1.  Intrathecal tetanus immunoglobulin.

Authors:  Milind S Tullu; Sandeep B Bavdekar
Journal:  Indian J Pediatr       Date:  2007-07       Impact factor: 1.967

2.  Two cases of acute dysphagia.

Authors:  R S Bhadauria; P V Padman
Journal:  Med J Armed Forces India       Date:  2012-08-14

Review 3.  Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms.

Authors:  Bjørnar Hassel
Journal:  Toxins (Basel)       Date:  2013-01-08       Impact factor: 4.546

4.  Current practice in the management of tetanus.

Authors:  Geeta M Govindaraj; Arakkal Riyaz
Journal:  Crit Care       Date:  2014-05-27       Impact factor: 9.097

Review 5.  Pharmacological management of tetanus: an evidence-based review.

Authors:  Chaturaka Rodrigo; Deepika Fernando; Senaka Rajapakse
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097

6.  Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial.

Authors:  Huỳnh Thị Loan; Lam Minh Yen; Evelyne Kestelyn; Nguyen Van Hao; Tran Tan Thanh; Nguyen Thi Phuong Dung; Hugo C Turner; Ronald B Geskus; Marcel Wolbers; Le Van Tan; H Rogier Van Doorn; Nicholas P Day; Duncan Wyncoll; Tran Tinh Hien; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites
Journal:  Wellcome Open Res       Date:  2018-11-05

7.  A systematic review of tetanus in individuals with previous tetanus toxoid immunization.

Authors:  J P Hopkins; C Riddle; M Hollidge; S E Wilson
Journal:  Can Commun Dis Rep       Date:  2014-10-16

8.  Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus.

Authors:  Mohammad Sami Walid; Fade Aziz Mahmoud
Journal:  Perm J       Date:  2009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.